ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapy

Peng-Ju Zhu; Ze-Zhou Yu; Qi-Dong You; Zheng-Yu Jiang
Drug Discovery Today2020-10-1DOI: 10.1016/j.drudis.2020.07.021
4阅读
引用收藏
分享

摘要

<br/>B-cell lymphoma-2 (Bcl-2) family proteins, comprising proapoptotic proteins (Bax and Bak), antiapoptotic proteins (Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and A1) and BCL-2 homology domain 3 (BH3)-only proteins (Bid, Noxa, and Puma), have long been identified as pivotal apoptosis regulators. As an antiapoptotic member, myeloid cell leukemin-1 (Mcl-1) can bind with proapoptotic proteins and inhibit apoptosis. Mcl-1 is frequently overexpressed and closely associated with oncogenesis and poor prognosis in several cancers, posing a tremendous obstacle for cancer therapy. Recently, an increasing number of Mcl-1-selective small-molecule inhibitors have entered preclinical studies and advanced into clinical trials. In this review, we briefly introduce the role of Mcl-1 in apoptosis and highlight the recent development of Mcl-1 small-molecule inhibitors.

相关
加载中…
  • Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments
    Yue, Jianda; Li, Yaqi; Li, Fengjiao; Zhang, Peng; Li, Yimin; Xu, Jiawei; Zhang, Qianqian; Zhang, Cheng; He, Xiao; Wang, Ying*; Liu, Zhonghua*Computers in Biology and Medicine, 2023, 152: 106350.
  • Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes.
    Respondek Michalina; Beberok Artur; Rzepka Zuzanna; Rok Jakub; Wrześniok DorotaPathology oncology research : POR , 2020, 26(3): 1465-1474.
  • Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathways
    Ruiz-Vela, Antonio*; Aggarwal, Mohit; de la Cueva, Palorna; Treda, Cezary; Herreros, Beatriz; Martfn-Perez, Daniel; Dominguez, Orlando; Piris, Miguel A.Blood, 2008, 111(3): 1665-1676.被引 17
查看全部 →

发表信息

论文状态
公开发表
期刊
Drug Discovery Today
发表日期
2020-10-01
卷期
第 25 卷, 第 10 期
页码
1873-1882
DOI
10.1016/j.drudis.2020.07.021
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIENCEDIRECT

作者

  • P

    Peng-Ju Zhu (第一作者)

  • Z

    Ze-Zhou Yu

查看全部 4 位作者收起作者
  • Q

    Qi-Dong You

  • Z

    Zheng-Yu Jiang

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417